Cardiac management in neuromuscular diseases

Area of Science:

• Neurology
• Cardiology
• Genetics

Background:

• Muscular dystrophies are a group of inherited disorders characterized by progressive muscle weakness and degeneration.
• Dystrophinopathies, including Duchenne and Becker muscular dystrophy, are the most common forms and serve as models for other dystrophies.
• Cardiac complications, such as cardiomyopathy and conduction abnormalities, are prevalent in muscular dystrophies.

Purpose of the Study:

• To provide a comprehensive overview of the pathophysiology, diagnostic approaches, and therapeutic options for common muscular dystrophies.
• To emphasize dystrophinopathies as a template for understanding and treating other muscular dystrophy forms.
• To discuss current and emerging cardiac management strategies for patients with muscular dystrophy.

Main Methods:

• Literature review of pathophysiology, diagnostics, and therapeutics for muscular dystrophies.
• Focus on dystrophinopathies and their treatment paradigms.
• Analysis of cardiac management, including pharmacotherapy, pacemakers, and defibrillators.

Main Results:

• Dystrophinopathies are the primary focus, with treatment strategies applicable to other forms.
• Cardiomyopathy management often involves angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
• Cardiac conduction abnormalities and ventricular tachydysrhythmias require interventions like pacemakers and internal cardiac defibrillators.

Conclusions:

• Effective management of muscular dystrophy requires a multidisciplinary approach, addressing both neuromuscular and cardiac aspects.
• Current therapeutic options for dystrophinopathies inform treatment for other muscular dystrophies.
• Advanced cardiac interventions are crucial for managing life-threatening arrhythmias and heart failure in muscular dystrophy patients.